StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research report report published on Thursday. The brokerage issued a sell rating on the basic materials company’s stock. Several other analysts have also issued reports on the stock. Lake Street Capital upgraded shares of Arcadia Biosciences to a strong-buy rating in […]